LianBio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Selling, General & Admin	66.68	65.6	36.88	13.98
Research & Development	39.88	59.76	158.69	120.89
Operating Expenses	106.56	125.35	195.57	134.87
Operating Income	-106.56	-125.35	-195.57	-134.87
Interest Expense / Income	0	0	0	4.85
Other Expense / Income	-19.45	-14.73	0.21	-0.12
Pretax Income	-87.11	-110.62	-195.78	-139.6
Income Tax	0.87	-0.33	0.52	0
Net Income	-87.98	-110.29	-196.3	-139.6
Shares Outstanding (Basic)	107	108	34	12
Shares Outstanding (Diluted)	107	108	34	12
Shares Change	-1.09%	213.78%	185.40%	-
EPS (Basic)	-0.81	-1.02	-5.71	-11.58
EPS (Diluted)	-0.81	-1.02	-5.71	-11.58
Free Cash Flow	-83.99	-101.03	-164.9	-99.03
Free Cash Flow Per Share	-0.78	-0.94	-4.79	-8.22
EBITDA	-85.86	-109.31	-195.36	-134.67
Depreciation & Amortization	1.25	1.31	0.42	0.08
EBIT	-87.11	-110.62	-195.78	-134.75

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).